U.S. Food and Drug Administration recently issued the following announcement.
Sclerosol Intrapleural Aerosol
Status: Currently in Shortage
»Date first posted: 02/16/2017
»Therapeutic Categories: Pulmonary/Allergy
Lymol Medical Corp. (Reverified 02/16/2017)
Company Contact Information: 781-935-0004
Presentation: Sclerosol 4 GM (NDC 63256-100-30)
Availability and Estimated Shortage Duration: To be determined
Shortage Reason (per FDASIA): Other
Original source can be found here.